Western blots also showed knockdown of Beclin‐1 resulted in increase in cleaved caspase‐3 and PARP in NEK2‐OE MM cells when treated with BTZ (Fig. 5F). The gene discussed is NEK2; the disease is Miyoshi myopathy.